title: Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy.
authors.affiliation: Department of Medicine, Division of Nephrology, St. Louis University Medical Center, Veterans Affairs St. Louis Health Care System, 3635 Vista Avenue, St. Louis, 63110 Missouri, USA.
authors.forename: Hala
authors.initials: H
authors.lastname: Yamout
authors.affiliation: ASH Comprehensive Hypertension Center, Section of Endocrinology, Diabetes and Metabolism, The University of Chicago Medicine, 5841 S. Maryland Ave. MC 1027, Chicago, 60637 Illinois, USA.
authors.forename: George L
authors.initials: GL
authors.lastname: Bakris
mesh_terms: D003928:Diabetic Nephropathies; D018450:Disease Progression; D006801:Humans; D051297:Sodium-Glucose Transporter 2
chemical_list: D051297:Sodium-Glucose Transporter 2